Francisco Rivas
Papers
3
Total Citations
27
H-Index
2
About
Dr. Francisco Rivas is a pioneering thoracic surgeon whose research centers on advancing minimally invasive surgical techniques for lung cancer treatment, with a particular focus on robotic-assisted thoracic surgery (RATS). His work has fundamentally shaped our understanding of how robotic platforms can improve oncologic outcomes in non-small cell lung cancer (NSCLC) patients. In his landmark 2023 study comparing total thoracoscopic and robotic surgery for lymphadenectomy—cited 17 times—Dr. Rivas demonstrated that RATS achieves superior lymph node dissection quality, a critical factor in accurate staging and long-term survival. He further expanded the field by investigating how preoperative nutritional and inflammatory status (8 citations) influences perioperative outcomes following robotic surgery, providing surgeons with evidence-based tools to optimize patient selection and recovery. Most recently, his 2024 work (2 citations) has broken new ground by showing that neoadjuvant chemoimmunotherapy, while increasing surgical complexity, does not compromise outcomes in robotic lung resections—a finding that directly impacts treatment protocols for locally advanced NSCLC. Dr. Rivas’s cumulative contributions have established him as a leading voice in the integration of robotics into thoracic oncology, bridging the gap between technological innovation and patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3